Charles Duncan

Piper Jaffray & Co.

Image: Charles Duncan

Dr. Charles Duncan is a managing director and senior research analyst at Piper Jaffray & Co. focusing on small- and mid-cap emerging growth biotechnology companies. Duncan brings more than 18 years of sellside experience and has been recognized by industry sources, including the StarMine Analyst Awards, as being among the best analysts for his fundamental and timely analysis. He is a graduate of the University of Wisconsin and holds a doctorate in neuropharmacology from the University of Colorado.

Recent Quotes

"INO reported 2Q17 financial results, including $92M in cash prior to the recent $71M capital raise."

— Charles Duncan, Piper Jaffray & Co. (8/9/17)
more >

Due to permission requirements, not all quotes are shown.